The Chairman of the Medicines Authority receives the Assistant Director of the World Health Organization for Medicines and Health Products Affairs
Dr. Ali Al-Ghamrawi, Chairman of the Egyptian Medicines Authority, received today a high-level delegation from the World Health Organization headed by Dr. Yukiko Nakatani, Assistant Director-General of the World Health Organization for Medicines and Health Products Affairs, within the framework of joint cooperation and the World Health Organization’s efforts to support healthcare systems. Egyptian Drug Control.
At the beginning of the meeting, Dr. Ali Al-Ghamrawi expressed his pride in cooperating with the World Health Organization, stressing that the authority always seeks to develop its performance in line with international standards, with Focusing on achieving pharmaceutical security for Egypt and the region. For her part, Dr. Yukiko Nakatani praised the great efforts made by the Egyptian Medicines Authority, stressing the World Health Organization’s continued support to enhance the authority’s position and leadership role in the region, in a way that supports environmental and health goals.
During the meeting, ways to enhance cooperation in various fields and the support provided by the World Health Organization to the Authority’s efforts to achieve the WLA level (a global reference body), which represents an advanced step towards leadership in regulating the pharmaceutical industries, and strengthening regional capabilities in regulatory fields, were discussed. And legislative, in addition to strengthening Egypt’s role as a regional platform for health cooperation, and achieving sustainability in the pharmaceutical industry sector by reducing the environmental impact of these industries.
She also pointed to the prominent role of Egypt and its importance to the organization, specifically to the Eastern Mediterranean region, and its linkage between markets. Pharmaceuticals in the continents of Africa and Asia in light of the organization’s accreditation of the Egyptian Medicines Authority for the third maturity level.
As part of the activities of the visit, the World Health Organization delegation toured the Egyptian Medicines Authority’s laboratories in which it was briefed on the latest devices. The Authority’s various analysis systems and work methods, which include a variety of regulatory services carried out by the Authority. The delegation also made another field trip to the Biogeneric factory. During which he viewed the latest technologies used in manufacturing medicines and vaccines, and received a detailed presentation on the progress made in the vaccine manufacturing project using mRNA, which Egypt had previously obtained as part of its leadership On the African continent, which represents a qualitative leap in the field of pharmaceutical innovation, and reflects Egypt’s creative capabilities at the regional and international levels.
The meeting was attended by the Egyptian Medicine Authority, Dr. Tamer Al-Husseini, Vice President of the Authority, and Dr. Rasha Ziadeh, Assistant to the President of the Authority for Affairs. Technical development and capacity development, Dr. Yass Rajai, Assistant to the Chairman of the Authority for Media Affairs and Investment Support, Dr. Amani Jawdat, Assistant to the Chairman of the Authority and Supervisor of the Central Administration of the Office of the Chairman of the Authority, and Dr. Miriam Boulos, Head of the Central Administration for Medical Supplies, Dr. Sherine Abdel Gawad, Head of the Central Administration for Pharmaceutical Care, Dr. Osama Hatem, Assistant to the Chairman of the Authority for Drug Policies and International Cooperation and Supervisor of the Central Administration for Pharmaceutical Policies, Dr. Amira Mahjoub, Head of the Central Administration for Operations, and Dr. Widyan Younis, Chairman The Central Administration for Pharmaceutical Control, Dr. Dalia Abu Hussein, Director General of Quality and member of the Coordinating Committee for Pharmaceuticals in Africa, in addition to a number of officials. The Authority.
On the part of the World Health Organization, Dr. Hoda Langer, Regional Advisor to the World Health Organization for the Eastern Mediterranean Region (WHO-EMRO), Dr. Uday Nuseirat, Regional Representative of the World Health Organization (WHO-EMRO), and Dr. Jasser attended. Al-Karim and Dr. Mona Maarouf, representatives of the World Health Organization in Egypt.
This comes within the framework of close cooperation between the Egyptian Medicines Authority and the World Health Organization in the field of enhancing the quality of pharmaceutical industries and ensuring health security regionally. And internationally, in a way that contributes to achieving sustainable development of the health sector.
- For more: Elrisala website and for social networking, you can follow us on Facebook
- Source of information and images “rosaelyoussef”“
